TNF Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
TNF Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • TNF Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $18.3K, a 79.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $18.3K -$72.6K -79.9% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $25.8K -$81.8K -76% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $34.9K -$88.9K -71.8% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $47.4K -$92.3K -66.1% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $90.9K -$64.2K -41.4% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $108K -$62.7K -36.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $124K -$8.94K -6.73% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $140K -$9.35K -6.27% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $155K +$90.9K +142% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $170K +$95.4K +127% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $133K Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $149K -$378K -71.7% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $64.2K +$23.8K +58.7% Sep 30, 2021 10-Q/A 2021-11-15
Q2 2021 $74.9K -$78.8K -51.3% Jun 30, 2021 10-Q 2021-08-16
Q4 2020 $527K -$487K -48% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $40.5K Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $154K Jun 30, 2020 10-K 2021-03-01
Q1 2020 $269K Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $1.01M $0 0% Jan 2, 2020 10-Q/A 2021-11-15
Q4 2018 $1.01M Jan 2, 2019 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.